BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12184008)

  • 1. [The other face of statins].
    Kaletha K; Chodorowski Z; Sein Anand J; Szydłowska M; Rybakowska I; Nagel-Starczynowska G
    Przegl Lek; 2002; 59(4-5):364-6. PubMed ID: 12184008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of simvastatin on endothelial function in cardiac syndrome X patients.
    Fábián E; Varga A; Picano E; Vajo Z; Rónaszéki A; Csanády M
    Am J Cardiol; 2004 Sep; 94(5):652-5. PubMed ID: 15342302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of simvastatin and pravastatin on peroxidation of erythrocyte plasma membrane lipids in patients with type 2 hypercholesterolemia.
    Koter M; Franiak I; Broncel M; Chojnowska-Jezierska J
    Can J Physiol Pharmacol; 2003 May; 81(5):485-92. PubMed ID: 12774855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-administration of ezetimibe and simvastatin in acute myocardial infarction.
    Chenot F; Montant PF; Marcovitch O; Blaimont M; de Meester A; Descamps OS
    Eur J Clin Invest; 2007 May; 37(5):357-63. PubMed ID: 17461981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic determinants of response to statins.
    Peters BJ; Klungel OH; de Boer A; Maitland-van der Zee AH
    Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):977-83. PubMed ID: 19673675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
    J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of simvastatin on pro-inflammatory cytokines in patients with hypercholesterolemia.
    Zubelewicz-Szkodzińska B; Szkodziński J; Danikiewicz A; Romanowski W; Błazelonis A; Muc-Wierzgon M; Pietka-Rzycka A; Muryn Z
    Kardiol Pol; 2003 Dec; 59(12):465-74. PubMed ID: 14724693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol-lowering and vascular reactivity in relation to coronary heart disease.
    de Divitiis M; Rubba P
    Nutr Metab Cardiovasc Dis; 1999 Jun; 9(3):133-42. PubMed ID: 10464786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study.
    Borghi C; Dormi A; Veronesi M; Sangiorgi Z; Gaddi A;
    Am Heart J; 2004 Aug; 148(2):285-92. PubMed ID: 15308998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypercholesterolemia as cardiovascular risk in hypertensive patients. Therapeutic implications: efficiency of statins].
    Borghi C; Veronesi M
    Recenti Prog Med; 2003 Oct; 94(10):421-6. PubMed ID: 14619187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial cardiovascular pleiotropic effects of statins.
    Davignon J
    Circulation; 2004 Jun; 109(23 Suppl 1):III39-43. PubMed ID: 15198965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of low-dose simvastatin and ezetimibe compared to high-dose simvastatin alone on post-fat load endothelial function in patients with metabolic syndrome: a randomized double-blind crossover trial.
    Olijhoek JK; Hajer GR; van der Graaf Y; Dallinga-Thie GM; Visseren FL
    J Cardiovasc Pharmacol; 2008 Aug; 52(2):145-50. PubMed ID: 18670365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cholesterol-lowering therapy on endothelial function.
    Houghton JL
    Circulation; 2001 Jul; 104(2):E6. PubMed ID: 11447096
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lowering cholesterol: how low is low enough?].
    Czuriga I; Edes I
    Orv Hetil; 2006 Jul; 147(29):1349-56. PubMed ID: 16941825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins. Cholesterol-lowering and more in a pill.
    Mayo Clin Health Lett; 2001 Dec; 19(12):4-5. PubMed ID: 11766516
    [No Abstract]   [Full Text] [Related]  

  • 17. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.
    Daskalopoulou SS; Mikhailidis DP
    Curr Med Res Opin; 2006 Mar; 22(3):511-28. PubMed ID: 16574035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of beta-amyloid(1-40), beta-amyloid(1-42), and total beta-amyloid remain unaffected in adult patients with hypercholesterolemia after treatment with statins.
    Höglund K; Wiklund O; Vanderstichele H; Eikenberg O; Vanmechelen E; Blennow K
    Arch Neurol; 2004 Mar; 61(3):333-7. PubMed ID: 15023808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Additional effects of statins independent of the cholesterol-lowering as yet not shown to be clinically relevant].
    Stalenhoef AF; Stehouwer CD
    Ned Tijdschr Geneeskd; 2000 Feb; 144(7):308-10. PubMed ID: 10707739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of uncontrolled hyperlipidaemia in high-risk ambulatory patients in primary care.
    Hildemann S; Karmann B; Pittrow D; Barho C; Darius H; Bode C
    Curr Med Res Opin; 2008 Jun; 24(6):1659-68. PubMed ID: 18457604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.